HIGHLIGHTS
- who: Xiaoyu Ji et al. from the Department of Thyroid Surgery, The First Hospital of China Medical University, No, Nanjing North Street have published the article: The Emerging Role of m6A Modification in Endocrine Cancer, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW was of /2023/
- what: The m6A-modified genes may be the primary focus for cancer breakthroughs. The authors explore the role of m6A in regulating the development of OC through modulating protein translation. The study showed that compared with non-CSCs, the cAMP level in ovarian CSCs was significantly decreased . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.